Kun He

4.5k citations
53 papers · 3.2k indexed · 2 hit papers · h-index 27

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Treatments and Mutations

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 12
    • Cancer Immunotherapy and Biomarkers 11
    • Colorectal Cancer Treatments and Studies 7
    • CAR-T cell therapy research 5

Kun He

52 papers receiving 3.1k citations

Hit Papers

FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1 2016 · 285 citations
2852016202620192022100200300

Peers

Kun He
Comparison fields: 5 of 103
  • Oncology 2.0k
  • Pulmonary and Respiratory Medicine 1.3k
  • Cancer Research 475
  • Immunology 578
  • Hepatology 209
Replace Kirsten B. Goldberg with:
Kirsten B. Goldberg United States
Jun Gong United States
Amit Mahipal United States
Simon Pernot France
Shunchang Jiao China
Stefan Boeck Germany
Archie Tse United States
P. Murawa Poland
Andréa Varga France
Hidetoshi Hayashi Japan
Kun He relative to Kirsten B. Goldberg United States Kirsten B. Goldberg's profile →
Citations per field
00.5×5.7×
Kirsten B. Goldberg · 1×
Citations per year

Countries citing papers authored by Kun He

Since Specialization
Citations

This map shows the geographic impact of Kun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun He more than expected).

Fields of papers citing papers by Kun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun He. The network helps show where Kun He may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kun He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kun He Line = papers co-authored together Kun He links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20247
4 20243
5 20244
6 202330
7 20233
8 202313
9 202119
10 202116
11 202020
12
Modified poisoning severity score for early prognostic evaluation in acute paraquat poisoning
20181
13 2018112
14 2018171
15 2017228
16 2017172
17 201614
18 201637
19 201310
20 201221

About Kun He

Kun He is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Otorhinolaryngology, having authored 53 papers that have together received 3.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), CAR-T cell therapy research (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (475 citations), Immunology (578 citations) and Hepatology (209 citations). Kun He has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Richard Pazdur, Patricia Keegan, Gideon M. Blumenthal, Dickran Kazandjian, Huanyu Chen, Hong Zhao, Kirsten B. Goldberg, Xiaoping Jiang, Amy E. McKee and Sirisha L. Mushti. Their work appears in journals such as Clinical Cancer Research, The Oncologist, International Journal of Molecular Sciences, Scientific Reports and Cell Biology International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026